Blazing Star Merger Sub completes Walgreens debt tender offer
Investing.com - Jefferies upgraded Sai Life Sciences Ltd (SAILIFE:IN) to Buy from Hold on Monday, while raising its price target to INR1,000.00 from INR800.00.
The upgrade follows Sai Life Sciences’ first-quarter results, which Jefferies described as "an all-around beat" with strong performance in both Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) segments.
Jefferies highlighted the company’s plans to nearly double its manufacturing capacity over the next 18 months compared to its fiscal year 2025 base, citing strong order visibility and scale-up of existing projects.
The investment firm noted that Sai Life Sciences offers "the best near-term growth visibility backed by commercial projects" at a time when several Indian CDRMOs are facing destocking challenges.
Jefferies has increased its FY26-28E EBITDA estimates for the company by 1-3% following the results and expansion plans.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.